stockrowIDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +9.86%
- EPS
- +17.3%
- Free cash flow
- +17.6%
- Total debt
- −28.6%
Quarter to September 2026, against a year earlier
Follow IDXX
Alert me
IDEXX Laboratories, Inc. (IDXX) Total debt
IDEXX Laboratories, Inc.'s total debt at the end of fiscal 2025 was $449.8M, down 27.2% from $617.6M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $374.9M. Over the past ten years it has ranged from $449.8M (fiscal 2025) to $1.3B (fiscal 2017) — the current reading is the lowest in ten years. IDEXX Laboratories, Inc. ranks 19th of 46 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $449.8M | (27.16%) |
| FY2024 | $617.6M | (11.51%) |
| FY2023 | $697.9M | (9.29%) |
| FY2022 | $769.4M | (9.51%) |
| FY2021 | $850.2M | (6.42%) |
| FY2020 | $908.5M | (9.42%) |
| FY2019 | $1.0B | 0.26% |
| FY2018 | $1.0B | (20.67%) |
| FY2017 | $1.3B | 4.73% |
| FY2016 | $1.2B | 101.66% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $374.9M | (16.67%) |
| Jun 2026 | $449.9M | 0.00% |
| Mar 2026 | $449.9M | 0.00% |
| Dec 2025 | $449.8M | (14.29%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| IQV IQVIA Holdings Inc. compare | $16.1B |
| DGX Quest Diagnostics Incorporated compare | $5.6B |
| LH Labcorp Holdings Inc. compare | $5.3B |
| WAT Waters Corporation compare | $4.9B |
| A Agilent Technologies, Inc. compare | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| ILMN Illumina, Inc. compare | $1.8B |
| IDXX IDEXX Laboratories, Inc. | $374.9M |
| NTRA Natera, Inc. compare | $80.3M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement